Skip to main content
. 2020 May 4;12(5):1153. doi: 10.3390/cancers12051153

Figure 2.

Figure 2

Clinical ongoing approaches based on metabolic modulation as a strategy to improve the response to immune checkpoint inhibitors (ICI).